• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨钙敏感受体的作用机制及治疗学研究进展

The calcium-sensing receptor in bone--mechanistic and therapeutic insights.

机构信息

Department of Medicine, McGill University, 687 Pine Avenue West, Montreal, QC H3A 1A1, Canada.

出版信息

Nat Rev Endocrinol. 2015 May;11(5):298-307. doi: 10.1038/nrendo.2015.30. Epub 2015 Mar 10.

DOI:10.1038/nrendo.2015.30
PMID:25752283
Abstract

The extracellular calcium-sensing receptor, CaSR, is a member of the G protein-coupled receptor superfamily and has a critical role in modulating Ca(2+) homeostasis via its role in the parathyroid glands and kidneys. New evidence suggests that CaSR expression in cartilage and bone also directly regulates skeletal homeostasis. This Review discusses the role of CaSR in chondrocytes, through which CaSR contributes to the development of the cartilaginous growth plate, as well as in osteoblasts and osteoclasts, through which CaSR has effects on skeletal development and bone turnover in young and mature animals. The interaction of skeletal CaSR activation with parathyroid hormone (PTH), which is secreted by the parathyroid gland, can lead to net bone formation in trabecular bone or net bone resorption in cortical bone. Allosteric modulators of CaSR are beneficial in some clinical conditions, with effects that are mediated by the ability of these agents to alter levels of PTH and improve Ca(2+) homeostasis. However, further insights into the action of CaSR in bone cells might lead to CaSR-based drugs that maximize not only the effects of the receptor on the parathyroid glands and kidneys but also on bone.

摘要

细胞外钙敏感受体(CaSR)是 G 蛋白偶联受体超家族的成员,通过其在甲状旁腺和肾脏中的作用,在调节钙稳态方面发挥着关键作用。新的证据表明,软骨和骨骼中的 CaSR 表达也直接调节骨骼稳态。本综述讨论了 CaSR 在软骨细胞中的作用,通过该作用,CaSR 有助于软骨生长板的发育,以及在成骨细胞和破骨细胞中的作用,通过该作用,CaSR 对幼年和成年动物的骨骼发育和骨转换有影响。骨骼 CaSR 激活与甲状旁腺激素(PTH)的相互作用,甲状旁腺分泌 PTH,可导致小梁骨的净骨形成或皮质骨的净骨吸收。CaSR 的变构调节剂在某些临床情况下是有益的,其作用是通过这些药物改变 PTH 水平和改善钙稳态的能力来介导的。然而,进一步了解 CaSR 在骨细胞中的作用可能会导致基于 CaSR 的药物,这些药物不仅能最大限度地发挥受体对甲状旁腺和肾脏的作用,而且还能发挥对骨骼的作用。

相似文献

1
The calcium-sensing receptor in bone--mechanistic and therapeutic insights.骨钙敏感受体的作用机制及治疗学研究进展
Nat Rev Endocrinol. 2015 May;11(5):298-307. doi: 10.1038/nrendo.2015.30. Epub 2015 Mar 10.
2
The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development.细胞外钙敏感受体(CaSR)是骨骼发育的关键调节因子。
Sci Signal. 2008 Sep 2;1(35):ra1. doi: 10.1126/scisignal.1159945.
3
Interplay between CaSR and PTH1R signaling in skeletal development and osteoanabolism.钙敏感受体(CaSR)与甲状旁腺激素1型受体(PTH1R)信号通路在骨骼发育和骨合成代谢中的相互作用。
Semin Cell Dev Biol. 2016 Jan;49:11-23. doi: 10.1016/j.semcdb.2015.12.004. Epub 2015 Dec 10.
4
The calcium-sensing receptor in bone metabolism: from bench to bedside and back.骨代谢中的钙敏感受体:从实验室到临床再回归
Osteoporos Int. 2015 Aug;26(8):2055-71. doi: 10.1007/s00198-015-3203-1. Epub 2015 Jun 23.
5
[Impaired bone mineralization in calcium-sensing receptor (CaSR) knockout mice : the physiological action of CaSR in bone microenvironments].[钙敏感受体(CaSR)基因敲除小鼠的骨矿化受损:CaSR在骨微环境中的生理作用]
Clin Calcium. 2007 Oct;17(10):1567-73.
6
New insights in bone biology: unmasking skeletal effects of the extracellular calcium-sensing receptor.骨生物学的新见解:揭示细胞外钙敏感受体的骨骼效应。
Sci Signal. 2008 Sep 2;1(35):pe40. doi: 10.1126/scisignal.135pe40.
7
Role of the calcium-sensing receptor in extracellular calcium homeostasis.钙敏感受体在细胞外钙稳态中的作用。
Best Pract Res Clin Endocrinol Metab. 2013 Jun;27(3):333-43. doi: 10.1016/j.beem.2013.02.006. Epub 2013 Mar 13.
8
The calcium-sensing receptor complements parathyroid hormone-induced bone turnover in discrete skeletal compartments in mice.钙敏感受体在小鼠离散的骨骼腔室中补充甲状旁腺激素诱导的骨转换。
Am J Physiol Endocrinol Metab. 2012 Apr 1;302(7):E841-51. doi: 10.1152/ajpendo.00599.2011. Epub 2012 Jan 24.
9
The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.原发性甲状旁腺功能亢进症中的骨骼:一篇聚焦于骨重塑、结构、骨量和骨折的综述
APMIS Suppl. 2001(102):1-52.
10
Effect of the water fraction isolated from Fructus Ligustri Lucidi extract on bone metabolism via antagonizing a calcium-sensing receptor in experimental type 1 diabetic rats.女贞子水提物部位通过拮抗钙敏感受体对 1 型糖尿病大鼠骨代谢的影响。
Food Funct. 2017 Dec 13;8(12):4703-4712. doi: 10.1039/c7fo01259d.

引用本文的文献

1
Comparative analysis of blood whole transcriptome profiles in Yili horses pre- and post-5000-meter racing.伊犁马5000米赛跑前后血液全转录组图谱的比较分析
Front Genet. 2025 Aug 29;16:1651628. doi: 10.3389/fgene.2025.1651628. eCollection 2025.
2
Levo-Tryptophan Promotes Osteogenesis Through Calcium-Sensing Receptor.左旋色氨酸通过钙敏感受体促进骨生成。
FASEB Bioadv. 2025 Sep 3;7(8):e70045. doi: 10.1096/fba.2025-00130. eCollection 2025 Aug.
3
The function of GPCRs in different bone cells.G蛋白偶联受体(GPCRs)在不同骨细胞中的功能。

本文引用的文献

1
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.拟钙剂用于慢性肾病患者继发性甲状旁腺功能亢进的治疗
Cochrane Database Syst Rev. 2014;2014(12):CD006254. doi: 10.1002/14651858.CD006254.pub2. Epub 2014 Dec 9.
2
Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism.西那卡塞长期治疗继发性甲状旁腺功能亢进透析患者前后的骨组织形态计量学研究
Kidney Int. 2015 Apr;87(4):846-56. doi: 10.1038/ki.2014.349. Epub 2014 Oct 22.
3
Early predictors of hypocalcemia after total thyroidectomy: an analysis of 304 patients using a short-stay monitoring protocol.
Int J Biol Sci. 2025 Jul 24;21(11):4736-4761. doi: 10.7150/ijbs.113585. eCollection 2025.
4
Orai1 is Required for Osteogenic Differentiation on Nanoparticulate Mineralized Collagen Glycosaminoglycan Materials.纳米颗粒矿化胶原糖胺聚糖材料上的成骨分化需要Orai1。
Macromol Biosci. 2025 Jul 13:e00636. doi: 10.1002/mabi.202400636.
5
The calcium-sensing receptor: a comprehensive review on its role in calcium homeostasis and therapeutic implications.钙敏感受体:关于其在钙稳态中的作用及治疗意义的全面综述
Am J Transl Res. 2025 Mar 15;17(3):2322-2338. doi: 10.62347/QGTS5711. eCollection 2025.
6
Molecular mechanism for transcriptional regulation of the parathyroid hormone gene by Epiprofin.Epiprofin对甲状旁腺激素基因转录调控的分子机制
FEBS J. 2025 Mar 31. doi: 10.1111/febs.70085.
7
From hard tissues to beyond: Progress and challenges of strontium-containing biomaterials in regenerative medicine applications.从硬组织到其他领域:含锶生物材料在再生医学应用中的进展与挑战
Bioact Mater. 2025 Mar 6;49:85-120. doi: 10.1016/j.bioactmat.2025.02.039. eCollection 2025 Jul.
8
Bio-Calcium from Skipjack Tuna Frame Attenuates Bone Loss in Ovariectomy-Induced Osteoporosis Rats.鲣鱼框架生物钙可减轻去卵巢诱导骨质疏松症大鼠的骨丢失。
Mar Drugs. 2024 Oct 16;22(10):472. doi: 10.3390/md22100472.
9
Effects of the Interaction between Dietary Vitamin D and Vitamin K on Growth, Skeletal Anomalies, and Expression of Bone and Calcium Metabolism-Related Genes in Juvenile Gilthead Seabream ().日粮维生素D与维生素K的相互作用对幼鱼金头鲷生长、骨骼异常以及骨和钙代谢相关基因表达的影响()
Animals (Basel). 2024 Sep 28;14(19):2808. doi: 10.3390/ani14192808.
10
Bone targeted nano-drug and nano-delivery.骨靶向纳米药物和纳米递药系统。
Bone Res. 2024 Sep 4;12(1):51. doi: 10.1038/s41413-024-00356-2.
全甲状腺切除术后低钙血症的早期预测因素:采用短期监测方案对304例患者的分析
JAMA Otolaryngol Head Neck Surg. 2014 Nov;140(11):1006-13. doi: 10.1001/jamaoto.2014.2435.
4
A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis.一项评估钙敏感受体拮抗剂 MK-5442 治疗绝经后骨质疏松症的 2 期、随机、安慰剂对照、剂量范围研究。
J Clin Endocrinol Metab. 2014 Nov;99(11):E2207-15. doi: 10.1210/jc.2013-4009. Epub 2014 Aug 28.
5
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication.盐酸西那卡塞在无手术指征的散发性原发性甲状旁腺功能亢进症中的潜在作用。
Endocrine. 2015 May;49(1):274-8. doi: 10.1007/s12020-014-0381-0. Epub 2014 Aug 15.
6
Factors associated with vertebral fracture risk in patients with primary hyperparathyroidism.与原发性甲状旁腺功能亢进症患者椎体骨折风险相关的因素。
Eur J Endocrinol. 2014 Sep;171(3):399-406. doi: 10.1530/EJE-14-0343. Epub 2014 Jun 25.
7
Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription.甲状旁腺激素激活孤儿核受体 Nurr1 诱导 FGF23 转录。
Kidney Int. 2014 Dec;86(6):1106-15. doi: 10.1038/ki.2014.215. Epub 2014 Jun 18.
8
Increased trabecular volumetric bone mass density in Familial Hypocalciuric Hypercalcemia (FHH) type 1: a cross-sectional study.1型家族性低钙血症性高钙血症(FHH)患者小梁骨体积骨密度增加:一项横断面研究。
Calcif Tissue Int. 2014 Aug;95(2):141-52. doi: 10.1007/s00223-014-9877-0. Epub 2014 Jun 4.
9
Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations.全基因组关联研究的荟萃分析确定了血清钙浓度的 6 个新位点。
PLoS Genet. 2013;9(9):e1003796. doi: 10.1371/journal.pgen.1003796. Epub 2013 Sep 19.
10
Calcimimetic and calcilytic drugs for treating bone and mineral-related disorders.治疗骨和矿物质相关疾病的拟钙剂和钙敏感受体激动剂类药物。
Best Pract Res Clin Endocrinol Metab. 2013 Jun;27(3):373-84. doi: 10.1016/j.beem.2013.02.008. Epub 2013 Mar 27.